Ipratropium Bromide | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Ipratropium Bromide
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ipratropium Bromide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 8 USDMF, 9 CEP/COS, 1 JDMF, 5 EU WC, 9 KDMF, 15 NDC API, 20 Listed Suppliers, $ API Reference Price

25 API Suppliers
8 USDMF
9 CEP/COS
1 JDMF
5 EU WC
9 KDMF
15 NDC API
20 Listed Suppliers
$ API Reference Price

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

182 FDF Dossiers, 41 FDA Orange Book, 81 Europe, 17 Canada, 5 Australia, 23 South Africa, 15 Listed Dossiers

182 FDF Dossiers
41 FDA Orange Book
81 Europe
17 Canada
5 Australia
23 South Africa
15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.042MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - 0.042MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

5 Actylis, 1 Finar

5 Actylis
1 Finar

EXCIPIENTS BY APPLICATIONS

4 Parenteral, 2 Solubilizers

4 Parenteral
2 Solubilizers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 13 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
13 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 56 Finished Drug Prices

1 US Medicaid Prescriptions
56 Finished Drug Prices

MARKET PLACE

10 APIs, 6 FDF Dossiers, 1 EXCIPIENTS

10 APIs
6 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

7 US Patents, 1 Health Canada Patents

7 US Patents
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 9 Others

4 EDQM
4 USP
9 Others

$ API Ref.Price (USD/KG) : 4,494 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Boehringer Ingelheim (Canada) Ltd.

filter Patent Reset all filters

1 All

01 12151383

filter Product Reset all filters

1 All

01 1Ipratropium Bromide

filter Dosage Reset all filters

1 All

01 1Metered-Dose (Aerosol)

filter Exp Date Reset all filters

1 All

01 12013-12-06

Vamsi labs Ipratropium Bromide

Product Main Page

01

Boehringer Ingelheim (Canada) Ltd.

Ipratropium Bromide

Pharmtech & Ingredients

Not Confirmed

Boehringer Ingelheim (Canada) Ltd.

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-06

Date Granted : 2005-02-08

Ipratropium Bromide

Brand Name : ATROVENT HFA

Patent Number : 2151383

Filing Date : 1993-12-06

Strength per Unit : 20 mcg/actuation

Dosage Form : Metered-Dose (Aerosol)

Human Or VET : Human

Route of Administration : Inhalation

Patent Expiration Date : 2013-12-06

Date Granted : 2005-02-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?